BCDA

NASD BioCardia, Inc.
Oct 12, 2026 · 11:31 PM ET EOD Market Closed

$1.02 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.02, $0.02 below the day’s high of $1.04

YTD change
-18.40%
vs 20-day SMA
-6.12%
vs 200-day SMA
-7.56%

Price ranges

Previous day
$1.02 $1.08
open $1.06 close $1.04
-$0.02 (-1.89%)
Today
$1.00 $1.04
open $1.04 now $1.02
-$0.02 (-1.92%)
Past week
$1.02 $1.11
from $1.04 now $1.02
-$0.02 (-1.92%)
Past month
$0.98 $1.40
from $1.08 now $1.02
-$0.06 (-5.56%)
This year
$0.75 $1.80
from $1.25 now $1.02
-$0.23 (-18.40%)

Price & Performance

-0.17 (-14.29%) / 6M

$0.7328$0.9180$1.10$1.29Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $78,547.30
  • BCDA is down 18% since the beginning of the year
  • BCDA is down 24% over the past 12 months
  • BCDA is down 6% over the past 1 month
  • 84% of all BCDA investors are betting against BCDA

BCDA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -32.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.4
Earnings momentum -90.5% Quarterly EPS growth
Quarterly change -90.5%

Valuation

P/E ratio N/A
Enterprise value $9.4M
Beta 0.85

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$980.0K
Debt$745.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $15.4M

BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $417.57 +0.65%
MRNA Moderna, Inc. $213.74 -5.00%
RVMD Revolution Medicines, Inc. $193.95 +2.21%
ROIV Roivant Sciences Ltd. $34.59 -2.40%
BNTX BioNTech SE Sponsored ADR $95.84 -1.16%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.